Publications: Mr James Boot
Vinel C, Boot J, Zabet R, Brandner S, Marino S
(
2023
)
.
STEM-02. SYNGN: A NOVEL EPIGENETIC PLATFORM FOR PATIENT-SPECIFIC DRUG-MATCHING IN GLIOBLASTOMA
.
Neuro-Oncology
vol.
25
,
(
Supplement_5
)
v33
-
v33
.
Li W, Garrido P, Mir IG, Waller K, Jong AD, Brindley JH, Khan W, Boot J et al.
(
2023
)
.
O23 Toll-like receptor 5 signalling mediates pro-inflammatory and fibrogenic responses in non-alcoholic steatohepatitis (NASH)
.
Conference:
Oral presentationsa12.1
-
a1a12
.
Li W, Garrido P, Mir IG, Waller K, Jong AV-D, Brindley JH, Khan W, Hood G et al.
(
2023
)
.
WED-406 Toll-like receptor 5 signalling mediates pro-inflammatory and fibrogenic responses in non-alcoholic steatohepatitis (NASH)
.
Journal of Hepatology
vol.
78
,
Boot J, Rosser G, Kancheva D, Vinel C, Lim YM, Pomella N, Zhang X, Guglielmi L et al.
(
2022
)
.
Global hypo-methylation in a proportion of glioblastoma enriched for an astrocytic signature is associated with increased invasion and altered immune landscape
.
eLife
vol.
11
,
Marino S
(
2021
)
.
Comparative epigenetic analysis of tumour initiating cells and syngeneic EPSC‐derived neural stem cells in glioblastoma
.
Nature Communications